drugset / Trial / NCT03328143

Feasibility of Aromatherapy in an Awake Craniotomy Environment

NCT03328143 ↗

Phase 1 Completed 40 enrolled Wake Forest University Health Sciences
NaSingle-groupOpen-labelOther

Summary

Awake craniotomy for tumor surgery allows for mapping of speech, motor and sensory function during tumor resection. Awake craniotomy is increasingly utilized as it has several advantages over a traditional general anesthetic technique. Though many patients tolerate awake cranial surgery well, recent studies found that roughly 30% of patients experience moderate to severe pain and anxiety, while 50% report moderate fear and 11% report severe fear. Therefore, alternative methods to mitigate pain, anxiety, and fear are needed. In this study, the investigators will employ lavender aromatherapy to reduce anxiety and improve the satisfaction with pain control.

Timeline

Start
2018-04-03
Primary completion
2019-06-12
Completion
2019-06-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Lavender (Lavandula angustifolia) Unknown 15 unknown Intranasal

Indications

No indication recorded.